Contrast-Enhanced Mammography (CEM) is a game changer in breast diagnostic imaging and biopsy care. GE HealthCare pioneered this technology in 2010 and is associated with over 200 publications that demonstrate its clinical performances.
GE HealthCare’s CEM combines the morphologic and density information similarly to a conventional mammogram and the functional vascular information of a breast MRI1. It presents an opportunity to create and implement a more streamlined workflow to help diagnosis breast cancer early. In addition to increasing patient access, our CEM offering boasts high levels of sensitivity and specificity, allowing for the detection of lesions that would otherwise go undetected2,3,4.
To ensure your practice can fully leverage the combined power of GE HealthCare contrast mammography solutions, we introduce Pristina Bright our comprehensive CEM package with complete implementations support.
Our most recent CEM release (Nira), image quality was assessed superior in more than 98% of the images presented by all the readers 6
SenoBright HD 003 Left Surgery Follow up
Exam for a 59 year old woman, post surgical follow-up demonstrating no contrast uptake and a true negative.
SenoBright HD 015, L DCIS+IDC, TP
Indication: BiRads 6 diagnosis to understand the extent of disease. Enhancement proved invasive ductal carcinoma and ductal carcinoma in-situ.
SenoBright HD 016, R DCIS, TP
Indication for a right breast palpation and CEM demonstrated additional finding in left breast. Biopsy results were ductal carcinoma in-situ.
57 year old Canadian female, very much an advocate for her own healthcare. She had a screening Mammo with Tomo at an outside imaging facility in July 2021 and was told BiRads 0.
View step 3 >>
We are prepared to help you through every step of the way as you navigate this technology for your facility. From implementation support to expert content, we have the knowledge to help you succeed in developing a comprehensive CEM program.
Implementation Support and Training
Expert Content
